Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments

Go back to Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments

Avid Bioservices (CDMO) Misses Q2 EPS by 2c, Revenue Beats

September 6, 2022 4:09 PM EDT

Avid Bioservices (NASDAQ: CDMO) reported Q2 EPS of $0.02, $0.02 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $36.7 million versus the consensus estimate of $33.44 million.

For earnings history and earnings-related data on Avid Bioservices (CDMO) click here.

... More